Figure 2.
Figure 2. Disease-free survival of patients with M7 and non-M7 AML. The median of disease-free survival for patients with M7 and non-M7 was 23 and 52 weeks, respectively (P < .001).

Disease-free survival of patients with M7 and non-M7 AML. The median of disease-free survival for patients with M7 and non-M7 was 23 and 52 weeks, respectively (P < .001).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal